Skip to main content

Advertisement

Log in

Biochemical markers of vascular calcification in elderly hemodialysis patients

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The increased vascular calcification, cardiovascular morbidity, and mortality in chronic kidney disease (CKD) patients has been associated with disturbances in mineral-bone metabolism. In order to determine markers of the vascular calcification frequently observed in these patients, blood samples of elderly male and female hemodialysis CKD patients were used to measure serum levels of: osteoprotegerin (OPG), total soluble receptor activator of nuclear factor-κB ligand (sRANKL), and fetuin-A by enzyme immunoassay; tartrate-resistant acid phosphatase (TRACP-5b), and bone-specific alkaline phosphatase (BAP) by immunoenzymometric assay; osteocalcin (OC) by ELISA; iPTH by immunoradiometric assay; 25(OH)D3 and 1,25(OH)2D3, by I125 radioimmunoassay; and calcium and phosphorus by photometric assay. Serum OPG, BAP, iPTH, phosphorus, and OC levels were higher and serum 25(OH)D3, 1,25(OH)2D3, and fetuin-A levels lower in both male and female CKD patients than in their respective controls. Our results indicate that the bone formation and resorption parameters are altered in elderly male and female hemodialysis CKD patients. These changes may lead to vascular calcifications and cardiovascular complications, given that elevated OPG and OC levels and reduced fetuin-A levels are associated with cardiovascular events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Locatelli F, Del Vecchio L, Manzoni C (1998) Morbidity and mortality on maintenance haemodialysis. Nephron 80:380–400

    Article  PubMed  CAS  Google Scholar 

  2. Van Kuijk JP, Flu WJ, Chonchol M, Welten GM, Verhagen HJ, Bax JJ, Poldermans D (2010) The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant 25:1882–1888

    Article  PubMed  Google Scholar 

  3. Wanner C, Zimmerman J, Quaschning T, Galle J (1997) Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int 62:S53–S55

    CAS  Google Scholar 

  4. Nestel PJ, Fidge NH, Tan MH (1982) Increased lipoprotein-remnant formation in chronic renal failure. New Eng J Med 307:329–333

    Article  PubMed  CAS  Google Scholar 

  5. Kasiske BL (1998) Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32:142–156

    Article  Google Scholar 

  6. Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadaa L, Sherrard DJ (1997) Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26:903–907

    Article  Google Scholar 

  7. Senti M, Romero R, Pedro-Botert J, Pelegri A, Nogues X, Rubies-Part J (1992) Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394–1399

    Article  PubMed  CAS  Google Scholar 

  8. Pawlak K, Pawlak D, Mysliwiec M (2004) Oxidative stress influences CC-Chemokine levels in hemodialyzed patients. Nephron Physiol 96:105–112

    Article  Google Scholar 

  9. Massy ZA, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: markers and management. J Nephrol 15:336–341

    PubMed  CAS  Google Scholar 

  10. Junguers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha BM (1997) Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 12:2597–2602

    Article  Google Scholar 

  11. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K (2000) Morphology of coronary atherosclerotic cardiovascular accidents lesions in patients with end-stage renal-failure. Nephrol Dial Transplant 15:218–223

    Article  PubMed  CAS  Google Scholar 

  12. Dellegrottaglie S, Sanz J, Rajagopalan S (2006) Vascular calcification in patients with chronic kidney disease. Blood Purif 24:56–62

    Article  PubMed  Google Scholar 

  13. Kestenbaum B, Belozeroff V (2007) Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest 37:607–622

    Article  PubMed  CAS  Google Scholar 

  14. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800–1809

    Article  PubMed  CAS  Google Scholar 

  15. Fitzpatrick LA, Severson A, Edwards WD, Imgram RT (1994) Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 94:1597–1604

    Article  PubMed  CAS  Google Scholar 

  16. Moe SM, O’Neill KD, Duan D, Ahmed S, Chem NX, Leapman SB, Fineberg N, Kopecky K (2002) Medical artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638–647

    Article  PubMed  Google Scholar 

  17. Abbadi M, Giachelli CM (2007) Mechanism of vascular calcification. Adv Chrononic Kidney Dis 14:54–66

    Article  Google Scholar 

  18. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393–2402

    Google Scholar 

  19. Ix JH, Shlipak MG, Sarnak MJ, Beck GJ, Greene T, Wang X, Kusek JW, Collins AJ, Levey AS, Menon V (2007) Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int 72:1394–1399

    Article  PubMed  CAS  Google Scholar 

  20. Osorio A, Ortega E, de Haro T, Torres JM, Sanchez P, Ruiz-Requena E (2011) Lipids profiles and oxidative stress parameters in male and female hemodialysis patients. Mol Cell Biochem 353:59–63

    Article  PubMed  CAS  Google Scholar 

  21. Jono S, Shioi A, Ikari Y, Nishizawa Y (2006) Vascular calcification in chronic kidney disease. J Bone Miner Metab 24:176–181

    Article  PubMed  Google Scholar 

  22. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239–1246

    Article  PubMed  CAS  Google Scholar 

  23. Michaud J, Naud J, Ouimet D, Demers C, Petit JL, Leblond FA, Bonnardeaux A, Gascon-Barré M, Pichette V (2010) Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 21:1488–1497

    Article  PubMed  CAS  Google Scholar 

  24. Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38:323–329

    Article  PubMed  CAS  Google Scholar 

  25. Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Moriniére P, Garabedian M, Eastwood J, Fournier A (1999) Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser’s zones independent of calcitriol? Kidney Int 55:2169–2177

    Article  PubMed  CAS  Google Scholar 

  26. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9–16

    Article  PubMed  CAS  Google Scholar 

  27. Sigrist MK, Levin A, McIntyre CW (2009) Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant 24:3157–3162

    Article  PubMed  CAS  Google Scholar 

  28. Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Tziamalis MP, Tsigris C, Kostaki MA, Perrea DN (2007) sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients. J Endocrinol Invest 30:762–766

    PubMed  CAS  Google Scholar 

  29. Osorio A, Ortega E, Torres JM, Sanchez P, Ruiz-Requena E (2011) Mineral-bone metabolism markers in young hemodialysis patients. Clin Biochem 44:1425–1428

    Article  PubMed  CAS  Google Scholar 

  30. Nitta K, Akiba T, Uchida K, Kawashima A, Yumura W, Kabaya T, Nihei H (2003) The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42:303–309

    Article  PubMed  CAS  Google Scholar 

  31. Avbersek-Luznik I, Balon BP, Rus I, Marc J (2005) Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 20:566–570

    Article  PubMed  CAS  Google Scholar 

  32. Klejna K, Naumnik B, Gasowska K, Mysliwiec M (2009) OPG/RANK/RANKL signaling system and its significance in nephrology. Folia Histochem Cytobiol 47:199–206

    Article  PubMed  Google Scholar 

  33. Hofbauer LC, Schoppet M (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358:257–259

    Article  PubMed  CAS  Google Scholar 

  34. Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S, Coll B, Fernandez E, Valdivielso JM (2009) RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 104:1041–1048

    Article  PubMed  CAS  Google Scholar 

  35. Van Campenhout A, Golledge J (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204:321–329

    Article  PubMed  Google Scholar 

  36. Montecucco F, Steffens S, Mach F (2007) The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? Clin Dev Immunol 2007:75805

    Article  PubMed  Google Scholar 

  37. Ketteler M, Bongartz P, Westenfeld R, Jahnen-Dechent W, Ketteler M (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827–833

    Article  PubMed  CAS  Google Scholar 

  38. Idelevich A, Rais Y, Monsonego-Ornan E (2011) Bone Gla protein increases HIF-1α-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol 31:55–71

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Magdalena Quintana for technical assistance and Richard Davies for revising the English text. This study was funded in part by grant CICYT/FEDER (BFU2008-06843) and by the Andalusian Regional Government (Endocrinology & Metabolism Group).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Esperanza Ortega.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Osorio, A., Ortega, E., Torres, J.M. et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. Mol Cell Biochem 374, 21–27 (2013). https://doi.org/10.1007/s11010-012-1500-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-012-1500-y

Keywords

Navigation